U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"I watched his countenance closely, to see if he was not deranged ... and I was assured by other senators after he left the room that they had no confidence in it."

U.S. Senator Smith of Indiana ; After seeing Samuel Morse demonstrate the telegraph.

Newsletter  PatentStorm News

Make the Most of PatentStorm

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest patents by subscribing to an RSS feed.

Got questions? Ask a Patent Expert!

Registered users: Manage your profile, comments and alerts.

 

Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem


Location: Jerusalem, IL
No. of patents: 262

1              
NumberTitleIssue Date
7534605CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
An isolated polypeptide is provided. The isolated polypeptide comprising an antigen recognition domain capable of specifically binding a CD44 polypeptide as set forth in SEQ ID NO: 2 and incapable of binding a CD44 polypeptide selected from the group consisting of: ...
05/19/2009
7528947Nanoparticles functionalized probes and methods for preparing such probes
The present invention provides probes functionalized with nanoparticles, methods for binding nanoparticles to the probes and the use of such probes in nanometer scale imaging techniques. More specifically, the present invention provides a tip device having at least ...
05/05/2009
7528227Histone H2A peptide derivatives and uses thereof
Peptides derived from a segment of human histone H2A, the segment corresponding to amino acid residues 36-44 of human histone H2A, are capable of reducing or ameliorating the extent of injury induced by noxious stimuli when administered to animals. Pharmaceutical co...
05/05/2009
7504384Use of lipid conjugates in the treatment of infection
This invention provides compounds and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular pathogens. Also provided are compounds and methods of use thereof in s...
03/17/2009
7504099Methods of inducing or enhancing connective tissue repair
This invention provides method for repairing, regenerating, treating, or inducing the repair of an injury, a defect or a condition of a connective tissue of a subject. This invention provides a method of regenerating, enhancing, inducing repair and/or development of...
03/17/2009
7456154Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
The invention relates to an antisense oligonucleotide targeted to the coding region of the human acetylcholinesterase (AChE), which selectively suppresses the AChE-R isoform of the enzyme. The antisense oligonucleotide is intended for use in the treatment and/or pre...
11/25/2008
7425322Responsive biomedical composites
A responsive polymeric system including a responsive polymeric component capable of undergoing a transition that results in a sharp increase in viscosity in response to a triggering effected at a predetermined body site. The system includes a solid non-ceramic reinf...
09/16/2008
7407753Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis
The present invention uncovers a highly significant association of SNPs in the CNR2 locus, encoding the cannabinoid receptor 2 protein, with osteoporosis. Methods and kits for determining predisposition to osteoporosis, improving diagnosis in individuals suspected o...
08/05/2008
7393938Use of lipid conjugates in the treatment of diseases
This invention provides compounds represented by the structure of the general formula (A): wherein L is a lipid or a phospholipid, Z is either nothing, ethanolamine, serine, inositol, choline, or glycerol, Y is either nothi...
07/01/2008
7378438Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
The present invention relates to multifunctional β-agonist compounds comprising a reactive oxygen species scavenger group and a nitric oxide donor, and their use for the treatment of respiratory diseases involving airway obstruction, such as asthma and chronic bron...
05/27/2008
7365247Method of large scale mutagenesis in tomato plants
The present invention relates to a rapid and large-scale production of tomato mutants by utilizing a miniature tomato plant which can be crossed with tomato commercial plants. Mutations are induced in the miniature tomato cultivars and desired mutants are subsequent...
04/29/2008
7351527Immunizing fish against viral infection
The present invention provides the isolated causative agent of the disease affecting Cyprinus carpino and a method for its isolation. The invention further provides avirulent forms, e.g., live-attenuated form, inactivated form and genetically modified forms o...
04/01/2008
7345033Carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them
The present invention provides a compound of the following formula I: R3—NH—C(═X)—P(═O)OR1OR2 including pharmaceutically acceptable salts, solvates, hydrates and polymorphs of the compounds of formula I...
03/18/2008
7303760Method for treating multi-drug resistant tumors
Methods for administering mitomycin C to a multi-drug resistant cell and for reducing the toxicity of the compound are described. In the methods, mitoymic C is provided in the form of a prodrug conjugate, where the drug is linked to a hydrophobic moiety, such as a l...
12/04/2007
7305144System and method for compressing the dynamic range of an image
A gradient domain compression system generates, from an input image having a high luminance dynamic range, an output image having a lower luminance dynamic range. The system comprises a gradient image generator module, a gradient compression module, and an output im...
12/04/2007
7297540Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
Methods of generating, and isolating adult stem cells and utilizing such cells and/or embryonic stem cells in generating tissue of a specific function and micro-architecture are provided. ...
11/20/2007
7253341Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
Novel denaturant-stable, protease resistant, homo-oligomeric proteins, also referred to herein as stable proteins (SPs), having chaperone-like activity; methods of production and purification of SPs; nucleic acids encoding SPs; methods of isolating nucleic acids enc...
08/07/2007
7238656Protective factors against inflammation, burns and noxious stimuli
Peptide factors isolated from skin following exposure to chemical or thermal injury and treatment with iodine preparations are capable of reducing or ameliorating the extent of injury when administered to other animals. Specific peptides, including fragments of hist...
07/03/2007
7232929Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
The invention relates to new 2,2,3,3-tetramethylcyclopropane carboxamide derivative compounds, pharmaceutical compositions thereof and uses thereof for treating psychotic disorders, neurodegenerative diseases, epilepsy and pain. ...
06/19/2007
7223389Compositions and methods for treatment of cancer
The present invention discloses lentogenic viral strains useful in the treatment of cancer. A preferred viral strain of Newcastle Disease Virus (NDV) is specifically characterized in terms of biological activities. The present invention further discloses treatment o...
05/29/2007
7223902Method of producing recombinant β-glucosidase and an aroma spreading plant
The invention provides a method of producing a recombinant polypeptide having β-glucosidase enzymatic activity, a polynucleotide encoding the polypeptide, nucleic acid constructs carrying the polynucleotide, transformed cells, such as yeast cells, and transgenic or...
05/29/2007
RE39616Aminoindan derivatives
This invention is directed to compounds of the following formula: wherein when a is 0, b is 1 or 2; when a is 1, b is 1, m is from 0-3, X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is...
05/08/2007
7200318Near infra-red composite polymer-nanocrystal materials and electro-optical devices produced therefrom
The invention comprises a composite material comprising a host material in which are incorporated semiconductor nanocrystals. The host material is light-transmissive and/or light-emissive and is electrical chargetransporting thus permitting electrical charge transpo...
04/03/2007
7189692Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
Cyclic to Synthetic pseudopeptide derivatives of osteogenic growth polypeptide (OGP) and OGP(10-14) which are capable of enhancing bone cell proliferation and bone formation. Pharmaceutical composition comprising as active ingredient at least one pseudopeptide deriv...
03/13/2007
7189398Broad spectrum pyrogenic exotoxins antagonists and vaccines
The invention relates to peptides having an amino acid sequence substantially homologous to an amino sequence of a domain of a pyrogenic exotoxin, which domain forms a central turn in the exotoxin starting within β-strand 7 and connecting the β-strand 7, via short...
03/13/2007
7189414Controlled release oral drug delivery system
The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption an...
03/13/2007
7176498Terahertz radiating device based on semiconductor coupled quantum wells
A semiconductor device and method of its fabrication are provided to enable the device operation in a THz spectral range. The device comprises a heterostructure including at least first and second semiconductor layers. The first and second layers are made of materia...
02/13/2007
7174459Imprinting an identification certificate
A system and method for using imprinting as part of a security function that involves a user, for a security and/or identification mechanism. Imprinting is preferably used for cryptographic primitives, for determining a one-way function that operates at least partia...
02/06/2007
7172749Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
Radiolabeled epidermal growth factor receptor tyrosine kinase (EGFR-TK) irreversible inhibitors and their use as biomarkers for medicinal radioimaging such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) and as radiopharm...
02/06/2007
7141552Use of lipid conjugates in the treatment of diseases
The invention provides a method for treating a subject suffering from an intestinal disease, including, inter alia, Crohn's disease, ulcerative colitis, immuno-inflammatory intestinal injury, drug-induced enteropathy and ischemia-induced intestinal injury. This inve...
11/28/2006
7135295Detection of small molecules by use of a piezoelectric sensor
A protein comprising an antigen-binding portion formed by two cooperating peptide sequences of FIGS. 3A and 3B of the application. The protein may alternatively comprise an altered antigen-binding portion where at least one of the peptide sequences is ...
11/14/2006
7122668Platinum complexes and their use in therapy
The present invention concerns novel platinum complexes in which at least one of the amine ligand is a non-planar heterocyclic aliphatic amine. The platinum complexes may be in a trans or cis configuration and were found to posses therapeutic activites. Thus, the pr...
10/17/2006
7115161Ink-jet ink compositions based on oil-in-water microemulsion forming nanoparticles upon application on a surface
An Ink-jet ink composition for piezoelectric in-jet printing comprising: (a) a hydrophobic dye; (b) an oil-in-water microemulsion including: (i) a volatile oil; (ii) water; (iii) a co-solvent; (iv) at least one surfactant; and (v) a binder, wherein upon application ...
10/03/2006
7109993Method and system for the automatic computerized audio visual dubbing of movies
A method for automated computerized audio visual dubbing of a movie comprises (i) generating a three-dimensional head model of an actor in a movie, the head model being representative of specific facial features of the actor, and (ii) generating a three-dimensional ...
09/19/2006
7101864Compositions comprising oxophosphonate-based metalloproteinase inhibitors
The present invention relates to compositions useful for treating or controlling disease states or conditions associated with zinc containing proteinases, especially metalloproteinases. The active ingredient in these compositions is an alpha-oxo- or alpha-thixophosp...
09/05/2006
7101859Use of lipid conjugates in the treatment of diseases
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers. Phosphatidylethanolamine moieties conjugated to physiologically acceptable monomer...
09/05/2006
7101839Methods of and compositions for inhibiting the proliferation of mammalian cells
A method of preventing, inhibiting and/or reversing proliferation, colonization, differentiation and/or development of abnormally proliferating cells in a subject is disclosed. The method is effected by administering to the subject a therapeutically effective amount...
09/05/2006
7090995Molecules and methods using same for measuring non-transferrin bound iron
A molecule suitable for use as an indicator of free iron levels in a biological sample, the molecule including an iron binding moeity and a signal generating moeity, wherein an intensity of the signal generated by the signal generating moeity is related to an amount...
08/15/2006
7074915Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
The invention relates to an antisense oligonucleotide targeted to the coding region of the human acetylcholinesterase (AChE), which selectively suppresses the AChE-R isoform of the enzyme. The antisense oligonucleotide is intended for use in the treatment and/or pre...
07/11/2006
7067486Acetylcholinesterase-derived peptides and uses thereof
The invention relates to a cell growth and/or differentiation regulatory peptide comprising a sequence of about 9 to about 150 amino acids derived from acetylcholinesterase amino acid sequence, preferably from the C-terminal region of acetylcholinesterase. The inven...
06/27/2006
1              

Comments

No comments for this page
 
 
Forgot password?
Register here